West Pharmaceutical Services Total Non-Operating Income/Expense 2010-2024 | WST

West Pharmaceutical Services annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
  • West Pharmaceutical Services total non-operating income/expense for the quarter ending December 31, 2024 was $5M, a 27.4% decline year-over-year.
  • West Pharmaceutical Services total non-operating income/expense for the twelve months ending December 31, 2024 was $0.016B, a 29.09% decline year-over-year.
  • West Pharmaceutical Services annual total non-operating income/expense for 2024 was $0.016B, a 29.09% decline from 2023.
  • West Pharmaceutical Services annual total non-operating income/expense for 2023 was $0.022B, a 140.67% decline from 2022.
  • West Pharmaceutical Services annual total non-operating income/expense for 2022 was $-0.054B, a 1491.18% increase from 2021.
West Pharmaceutical Services Annual Total Non-Operating Income/Expense
(Millions of US $)
2024 $16
2023 $22
2022 $-54
2021 $-3
2020 $-6
2019 $-5
2018 $0
2017 $-3
2016 $-5
2015 $-13
2014 $-13
2013 $-15
2012 $-27
2011 $-17
2010 $-16
2009 $-14
West Pharmaceutical Services Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-12-31 $5
2024-09-30 $3
2024-06-30 $3
2024-03-31 $5
2023-12-31 $7
2023-09-30 $10
2023-06-30 $2
2023-03-31 $3
2022-12-31 $-1
2022-09-30 $-50
2022-06-30 $-1
2022-03-31 $-2
2021-12-31 $-2
2021-09-30 $0
2021-06-30 $0
2021-03-31 $-1
2020-12-31 $-1
2020-09-30 $-2
2020-06-30 $-2
2020-03-31 $-2
2019-12-31 $-1
2019-09-30 $-2
2019-06-30 $-1
2019-03-31 $-1
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $-1
2017-09-30 $0
2017-06-30 $-1
2017-03-31 $-1
2016-12-31 $1
2016-09-30 $-2
2016-06-30 $-2
2016-03-31 $-2
2015-12-31 $-3
2015-09-30 $-3
2015-06-30 $-3
2015-03-31 $-4
2014-12-31 $-3
2014-09-30 $-3
2014-06-30 $-4
2014-03-31 $-4
2013-12-31 $-3
2013-09-30 $-4
2013-06-30 $-4
2013-03-31 $-4
2012-12-31 $-3
2012-09-30 $-4
2012-06-30 $-16
2012-03-31 $-4
2011-12-31 $-4
2011-09-30 $-4
2011-06-30 $-4
2011-03-31 $-5
2010-12-31 $-4
2010-09-30 $-4
2010-06-30 $-4
2010-03-31 $-4
2009-12-31 $-4
2009-09-30 $-4
2009-06-30 $-3
2009-03-31 $-4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.984B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47